WATCH LIVE
timothy sykes logo
IVF Stock Slides As Traders Weigh Losses And Tight Liquidity Thumbnail
G Google News

IVF Stock Slides As Traders Weigh Losses And Tight Liquidity

TIM SYKES•UPDATED JUN. 26, 2026, 9:19 AM ET
Reviewed by Bryce Tuoheyand Fact-checked by Matt Monaco

INVO Fertility Inc. stocks have been trading up by 46.77 percent following highly favorable coverage of its fertility treatment potential.

Key Takeaways

  • IVF has retreated from recent highs near $2 to a recent close around $1.24, showing clear selling pressure on the daily chart.
  • Recent intraday trading in IVF featured heavy volatility between roughly $1.90 and $2.30, suggesting active day-trader interest but shaky conviction.
  • INVO Fertility Inc. prints strong gross margins near 55%, yet IVF still posts steep net losses and heavily negative returns on equity.
  • IVF carries about $4.9M in cash but also negative working capital, so traders must factor in funding and dilution risk alongside any momentum setup.

Candlestick Chart

Live Update At 09:18:31 EDT: On Friday, June 26, 2026 INVO Fertility Inc. stock [NASDAQ: IVF] is trending up by 46.77%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

IVF is a classic small-cap biotech-style story: big promise, ugly numbers. INVO Fertility Inc. generated about $6.8M in annual revenue, and IVF has grown that top line sharply over the past three and five years. The problem is what happens after revenue comes in.

IVF’s EBIT margin sits around -116%, with total profit margins even worse. That tells traders every dollar of sales is still buried under operating and financing costs. Return on equity near -145% and return on assets deep in the red confirm that INVO Fertility Inc. is not yet turning its asset base into profits.

More Breaking News

On the flip side, IVF trades at a very low price-to-sales ratio near 0.36 and a price-to-book around 0.17. That means the market values INVO Fertility Inc. at a steep discount to its accounting equity and revenue stream. For traders, cheap can stay cheap, but these numbers often attract speculative runs when sentiment flips. With a current ratio around 0.9 and quick ratio near 0.8, IVF has limited short-term breathing room, so any extended downtrend in the stock may increase pressure to raise capital.

Why Traders Are Watching IVF Price Swings

IVF has given active traders a clear story on the chart. From early June 2026, INVO Fertility Inc. pushed from around $1.47 to intraday spikes above $2.00, including a strong surge on 2026/06/04 where the high tagged roughly $2.08 before closing near $1.66. That kind of range shows there is real speculative energy in IVF when volume comes in.

Since then, the daily candles have shifted. IVF has been grinding lower, with closes stepping down from the $1.60–$1.70 zone to $1.59, then $1.50, then into the mid-$1.30s. The latest close around $1.24, after an intraday low near $1.20, tells traders supply is currently in control. For a stock like INVO Fertility Inc., which lives on sentiment and future potential, that loss of momentum matters.

Drill into the intraday data and you see IVF trading like a pure day-trading vehicle. Five-minute candles swinging between $1.90 and over $2.30, big wicks, quick reversals. INVO Fertility Inc. opened one recent session near $1.90, ripped into the $2.30s, then faded back under $2.10. That’s textbook momentum followed by profit-taking and possibly short selling.

Technically, traders are eyeing the $1.20–$1.30 area as a near-term line in the sand. If IVF holds and bounces, prior resistance in the $1.60–$1.80 band becomes the next target zone. If INVO Fertility Inc. loses $1.20 with volume, the chart opens space toward prior supports and raises the odds of a deeper flush, especially given the weak fundamentals.

Conclusion

For active traders, IVF is a tension play between discounted valuation and harsh reality. INVO Fertility Inc. shows solid gross margins, which means the core service has pricing power, but operating costs and financing needs are still crushing the bottom line. IVF reported about $4.9M in cash at the end of the last quarter and roughly $9.6M in total liabilities, with negative working capital around -$0.6M. That mix keeps dilution and capital raises firmly in the picture whenever the stock pops.

Price action backs up that caution. IVF has been fading from its early-June push above $2, with INVO Fertility Inc. now trading closer to $1.20–$1.30. Short-term bounces are always possible in this kind of low-float, low-priced name, but traders who chase need clear risk levels. The intraday tape already shows IVF can move $0.20–$0.40 per day, which is huge relative to its price.

The trading lesson here is simple. IVF rewards preparation, not hope. As Tim Sykes likes to say, “The market doesn’t care about your opinion, only your preparation.” As millionaire penny stock trader and teacher Tim Sykes, says, “The goal is not to win every trade but to protect your capital and keep moving forward.”. For those tracking INVO Fertility Inc., that means studying daily and intraday charts, understanding the balance sheet stress, and treating every IVF trade as a planned, research-driven setup — purely for education and research, never as blind conviction.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”